Samik Pharmaceutical Company LTD.

₩5,950As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:014950Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.67%
ROE (2.37%)
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM (67.39%)
Mkt cap ₩59.90B
ROIC 4.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,126
2.96%
(39.00%)
Hold 10|12|2|5|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
69.00
66.15
66.73
73.50
7.89%
7.38%
6.65%
16.29%
Revenue₩B
7.709
7.906
8.168
8.045
8.11%
6.79%
9.86%
4.14%
Peers (US$44.16M)
Cap (US$)
PE
46.94M
—
Capital
TTM
5Y
10Y
Leveragex
2.685
0.179
0.155
EBIT/Intx
0.374
0.108
0.096
Own earn%
(44.47)
22.60
25.35
Sh yield%
16.78
17.43
17.02
Owners
Insiders/Inst%
12.02
41.27
Short interest%
5.17
SBC / revenue%
2.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
15